Approval · Notice of Compliance 3604 · 2003
CYKLOKAPRON: Notice of Compliance 3604
Issued September 15, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3604
- Date
- September 15, 2003
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antifibrinolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYKLOKAPRON | 02064405 | Marketed |
| CYKLOKAPRON | 02064413 | Marketed |
Medicinal ingredients
- TRANEXAMIC ACID 500 MG per TAB
- TRANEXAMIC ACID 100 MG per ML